Echovirus is a type of virus that resides in the gastrointestinal (GI) tract. These viruses are collectively called Enteroviruses and are second only to rhinoviruses in prevalence. Echovirus derives its name from the ECHO (Enteric Cytopathic Human Orphan) virus. Generally, newborns, children, and young people are vulnerable to echovirus, as adults are more likely to have a developed immunity system; however, they can still become infected. Common symptoms of echovirus infection are cough, sore throat, flu, and rashes. Other symptoms include viral meningitis (that causes intense fever, chills, nausea, vomiting, and headache), myocarditis, encephalitis, and neonatal sepsis. There are no particular control measures or medicines for echovirus since its spread is infectious. However, it can be averted through executing great cleanliness practices and avoidance of shared utensils which may interfere with the transmission of the virus. A quick analysis of such viruses can help the patient from unnecessary treatment and lessen the length of hospitalization, thus reducing the overall expenditure for the treatment.
Major factors driving the global echovirus diagnostics market include rise in prevalence of echovirus infection among all ages of people due to its transmissible nature, technological advancements in molecular diagnostic techniques, and bioterrorism and availability of immunosuppressive drugs in a wide range. According to the CDC (Centers for Disease Control and Prevention), it has been estimated that around 12-14 million cases of symptomatic enterovirus infections are found in the U.S. every year. This means that infections with echovirus and enteroviruses are highly prevalent. In the U.S., the infection is more common during the summer and autumn seasons. Moreover, increase in government health programs, especially in developing nations, is expected to promote the echovirus diagnostics market in these regions.
Usually, echovirus infections are mild in nature and there are no specific treatment available for them. Thus, special tests are not performed for the diagnosis of Echovirus. Echovirus can be confirmed through laboratory tests, such as, rectal culture, stool culture, throat culture, and a spinal fluid culture. Segmentation of the echovirus diagnostics market can be done based on the clinical application, end-user and geography. On the basis of clinical application, the echovirus diagnostics market can be categorized into molecular diagnostics, immunoassays, differential light scattering, information technology, liposomes, flow cytometry, chromatography, gel micro-droplets, diagnostic imaging, monoclonal antibodies, and others. In terms of end-user, the echovirus diagnostics market can be divided into hospitals, commercial/private laboratories, physician offices, and public health labs.
On the basis of geography, the global echovirus diagnostics market can be distributed among five regions, viz. North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America held the leading share of the echovirus diagnostics market in 2017, followed by Europe. This can be attributed to the presence of a large number of leading echovirus diagnostics market players, technological advancements, and high health care expenditure in North America. In Europe, initiatives taken by the government in research & development are likely to drive the echovirus diagnostics market. Emerging countries of Asia Pacific are expected to witness high growth in the echovirus diagnostics market due to high prevalence of infections, large patient population, and developing health care technology. However, the developing nations of the Middle East and Latin America are expected to witness a sluggish growth due to poor health care facilities and limited investment in research and development.
Key players operating in the global echovirus diagnostics market include Abbott Laboratories, Inc., Gen-Probe, Inc., Danaher Corporation, Becton Dickinson and Company, Novartis Diagnostics, Qiagen, F. Hoffmann-La Roche Ltd., Siemens Ltd., Ortho-Clinical Diagnostics, Thermo Fisher Scientific, Inc., and Wallac OY.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.